COMBIGAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug COMBIGAN contains a combination of these active pharmaceutical ingredients (APIs):

1 Brimonidine
UNII 4S9CL2DY2H - BRIMONIDINE TARTRATE

Brimonidine is an alpha2-adrenergic receptor agonist that is 1000-fold more selective for the alpha2-adrenoceptor than the alpha1-adrenoreceptor. This selectivity results in no mydriasis and the absence of vasoconstriction in microvessels associated with human retinal xenografts.

Read about Brimonidine
2 Timolol
UNII P8Y54F701R - TIMOLOL MALEATE

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.

Read about Timolol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
COMBIGAN Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01ED51 Timolol, combinations S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 5535H, 8826M
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 501006001173319, 501006002171311
Country: CA Health Products and Food Branch Identifier(s): 02248347
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 27.158-07-06
Country: EE Ravimiamet Identifier(s): 1618635, 1618646
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 67438
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 036833, 050560
Country: FR Base de données publique des médicaments Identifier(s): 60657189
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 114771, 195414, 198693, 375750, 92069
Country: HK Department of Health Drug Office Identifier(s): 56799
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-496659610
Country: IE Health Products Regulatory Authority Identifier(s): 14312, 14320
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6069
Country: IT Agenzia del Farmaco Identifier(s): 037083019
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1071092, 1072277
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 627M2005
Country: NL Z-Index G-Standaard, PRK Identifier(s): 81159
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11390
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100159482
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69265001, W69265002
Country: SG Health Sciences Authority Identifier(s): 13406P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 3983031
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699490561102
Country: US FDA, National Drug Code Identifier(s): 0023-9211
Country: ZA Health Products Regulatory Authority Identifier(s): A39/15.4/0464

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.